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BACKGROUND: Chronic non-communicable diseases (NCDs) are 
a major global health problem of the 21 stcentury. They are now 
the world’s leading cause of disease burden and high mortality. An 
even more alarming health problem is when depression coexists 
with chronic NCDs, as is frequently the case. Management of this 
co-morbidity with collaborative care has become a global topic of 
interest, with the World Health Organization (WHO) 
recommending implementation of collaborative care for this 
purpose. The study investigated existing protocols and/or 
interventions for managing this co-morbidity in Rwandan district 
hospitals. 
METHODS: The study used an action research design involving a 
research team of 14 health care professionals to collaboratively 
identify existing protocols or interventions for managing co-
morbidity of depression and NCDs in Rwanda. Focus group 
discussion using a structured interview guide was used to collect 
qualitative data, followed by qualitative content analysis using 
inductive approach. 
RESULTS: We found no particular protocols or interventions in 
place to manage the co-morbidity of depression and chronic NCDs. 
Depression and chronic NCDs were found to be treated separately, 
in separate health care settings and by different health 
professionals.  
CONCLUSION:The findings revealed a gap in management of co-
morbid depression and chronic NCDs in Rwanda district hospitals. 
We recommend that health care providers follow the WHO 
collaborative care advisory for better quality care and better patient 
improvement in management of this co-morbidity. 
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INTRODUCTION   
 
Chronic NCDs are a major global health problem, 
causing morbidity and mortality in all countries(1-
3). More alarming still is when depression coexists 
with chronic NCDs (as is frequently the 
case),which is associated with major health 
consequences including high morbidity and 
mortality (4-9). Chronic NCDs that are frequently 
linked with depression include cardiovascular 
diseases, diabetes, cancer and chronic respiratory 
diseases (10-12). This co-morbidity has become a 
major concern worldwide, and optimal 
management of the problem is increasingly a topic 
of interest. A number of studies that have 
reviewed the management of this co-morbidity in 
various settings confirm that collaborative care is 
cost-effective in management of the co-morbidity 
(13-15). Collaborative care for management of co-
morbid depression and NCDs in primary care 
settings is  also recommended by the WHO (16). 
In low-income countries, it is, however, still 
frequently the case that mental health care is 
separate from physical care (17). This separation 
of treatment is associated with significant negative 
health  effects such as complex medication 
regimens with high risk of drug interactions and 
poor medication adherence, duplicative medical 
tests, unnecessary hospitalizations and increased 
mortality (13-15).  
The co-morbidity of depression and chronic 
NCDs in Rwanda is an ongoing concern for health 
care providers,with estimated prevalence of 
depression among diabetic and hypertensive 
patients,for example, being 27% and 29% 
respectively (18). Patients with chronic NCDs in 
Rwanda also face numerous difficulties in addition 
to the daily burden of managing their illnesses and 
their complications-difficulties common to 
patients from a developing country such as 
shortage of health care professionals, long 
distances to the health care settings and 
socioeconomic problems. Likewise, some of these 
patients have also been victims of the 1994 
genocide in Rwanda: orphans, widows, the 
unemployed, or simply those who have no one to 
care for them. All these difficulties make patients 
from Rwanda with chronic NCDs vulnerable to 
stress, anxiety and depression. 
The focus of this study was to investigate the 
current situation regarding management of co-
morbidity of depression and chromic NCDs in 
Rwanda district hospitals. It therefore aimed to 





This article is part of a larger study focussed on 
adapting the collaborative care model to the 
Rwandan context for management of co-morbid of 
depression and chronic NCDs. The study was 
ethically approved by the University of KwaZulu-
Natal Ethics  Committee, the University of 
Rwanda Institutional Review Board and the 
Rwanda Ministry of Health.  
Action research sequential–explanatory 
design with mixed methods was used for the larger 
study. The study was conducted in three cycles 
adapted from action research procedures (19). In 
the first cycle which was exploratory, the 
researcher identified the problem by exploring the 
prevalence of depression among diabetic and 
hypertensive patients and also the availability of 
protocol/interventions to manage this co 
morbidity. For this first cycle, mixed methods 
approach (Quantitative and qualitative) was used 
where quantitative approach was used to 
determine the prevalence of depression among 
participants with chronic NCDs represented by 
diabetes and hypertension in our study. While 
qualitative approach was used to identify existing 
protocol/interventions to manage this co 
morbidity. Therefore, this article presents the 
findings from the qualitative aspect which 
explored the current situation regarding 
management of the co-morbidity of depression 
and chronic NCDs in Rwanda district hospitals.  
The research areas were three selected district 
hospitals in Rwanda. The two first hospitals were 
district hospitals from urban area with 
endocrinology and mental health services, and the 
third hospital was a district hospital from a rural 
area with endocrinology and mental health 
services.  The selection of hospitals from urban 
area and one from rural area increased the chance 
of sample representation from both urban and 
rural settings.   
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In action research, researchers and health care 
practitioners come together to identify a problem 
and propose solutions (20). Accordingly, a 
research team of 14 health professionals (two 
psychiatrists, three medical doctors, three 
registered nurses, three chief nurses and three 
mental health nurses) participated in our study. 
Simple random sampling was used to choose the 
team members. They were all working in three 
participating hospitals except for two psychiatrists 
who were working in other settings (in Rwanda 
there are no psychiatrists based in district 
hospitals). The inclusion criteria for the medical 
doctors and registered nurses was that they were 
already working with patients with chronic NCDs. 
Focus group discussion was used as a method 
of data collection. The focus group was held at the 
University of Rwanda, precisely at the College of 
Medicine and Health Sciences. Before the 
discussion took place, the researcher provided 
more information about the purpose of the study 
and asked the team members who agreed to 
participate in the study to sign the informed 
consents . Interviews conducted by the researcher 
followed the key questions on the structured 
interview guide, with a range of answers from the 
various team members on each question. The 
researcher played a facilitating role, making sure 
that the group focused on the problem being 
explored and encouraging participation by every 
team member. Audio tape and note-taking were 
used, and the research assistant (a registered nurse 
working in the Department of Nursing at the 
University of Rwanda) helped in the note-taking. 
The focus group meeting lasted for two hours.  
Content analysis of qualitative data was done 
using inductive approach. Data analysis by was 
conducted in three phases, as outlined by Elo and 
Kyngäs(21): a preparation phase, an organizing 
phase and a reporting phase. In the preparation 
phase, data was read and reread, and units of 
analysis were chosen. In the organizing phase, 
categories and sub-categories were developed, 
while in the reporting phase, results were reported.  
Research ethics was respected as the study 
involved human beings. Care was taken at each 
stage on permission to conduct the study and 
respondents’ right to self-determination, privacy, 
anonymity, confidentiality, fair treatment and 
protection from harm and discomfort were 
observed. All participants signed the informed 
consent form. 





Gender  Position  Institution Experience 
01 Male  Psychiatrist  Psychiatric referral hospital  13 years 
02 Male Psychiatrist  Ministry of Health  10 years 
03 Male Medical doctor Hospital no. 1 5 years 
04 Male Medical doctor Hospital no. 2 6 years 
05 Male Medical doctor Hospital no. 3 3 years 
06 Female Chief of nursing Hospital no1 4 years 
07 Female Chief of nursing Hospital no. 2 6 years 
08 Female  Chief of nursing Hospital no. 3 8 years 
09 Female  Registered nurse Hospital no. 1 3 years 
10 Female  Registered nurse Hospital no. 2 6 years 
11 Female  Registered nurse Hospital no. 3 4 years 
12 Female  Mental health nurse Hospital no. 1 6 years 
13 Female  Mental health nurse Hospital no. 2 8 years  
14 Female  Mental health nurse  Hospital no. 3 4 years 
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Categories and sub-categories emerging from 
questions exploring the current management 
of co-morbidity 
 
Categories emerged from our analysis of 
data: 
 meaning of co-morbidity; 
 common co-morbidities; 
 awareness of co-morbid depression with 
chronic NCDs; 
 common NCDs associated with depression 
 screening tools of depression in patients 
with NCDs; 
 particular protocol or interventions to the 
management of co-morbidity of 
depression and NCDs. 
 
Meaning of co-morbidity: Participants offered 
various definitions which nonetheless  which 
correlated with one another; all were in 
agreement that co-morbidity of illnesses is the 
occurrence of more than one disease in the same 
person. 
Common co-morbidities in the district 
hospitals: When asked about common co-
morbidities that they had to deal with in their 
respective hospitals, most participants cited 
diabetes and hypertension. Also, frequently cited 
by the participants were co-morbidities not just 
of two diseases but also of three diseases (e.g. 
diabetes, hypertension and gastritis; diabetes, 
hypertension and asthma; diabetes, hypertension 
and depression). 
Awareness about co-morbid depression with 
chronic NCDs:  Participants’ responses when 
asked if they were aware of this co-morbidity 
were grouped, following analysis, into five sub-
categories: 
 awareness of occurrence of the co-
morbidity;  
 non-focus on depression; 
 suspected by some signs and symptoms; 
 referral of the patient if suspected to the 
mental unit; 
 no follow up of the patient. 
 
Awareness of occurrence of the co-morbidity 
 
 All respondents revealed that they knew very 
well that depression can occur any time in a 
patient with one or more chronic NCDs.  One 
participant said, “It is obvious, once you have a 
chronic disease, you have so many questions in 
your head, am I going to die? Till when will, I 
take these drugs? Sometimes, you don’t even eat, 
your lose appetite, then puff, depression is there, 
and you can’t help it”. 
 
Non-focus on depression: Although all 
participants acknowledged that depression may 
often occur in patients with chronic NCDs, they 
also agreed that depression in patients with 
NCDs is often unrecognized by health 
professionals or simply not there is remembered. 
One participant said, “We are aware of that co-
morbidity but most of time we don’t pay 
attention to it, mostly we focus on medical 
problem. Depression will be the last thing to 
think about”. Another comment was, “Most time 
we forget about depression  you know it is not 
our domain”. 
A psychiatric explained that if a patient 
with both depression and one or more than one 
chronic NCDs happens to visit the hospital or be 
hospitalized, he will in that case be referred to 
the general hospital to get treatment for the 
medical problem and then come back for the 
mental problem.  
Participants also explained that patients 
may not even recognize signs and symptoms of 
depression, and this may cause that most of them 
Don’t consult for depression, since they are 
unware that they may have it.  
 
Suspected from signs and symptoms: 
Participants explained that although depression 
is mostly unrecognized in patients with NCDs, 
with its signs and symptoms often being 
confused with those of the medical problem, 
there are some signs and symptoms which 
trigger suspicion of depression in a patient. One 
participants commented, “Depression will be the 
last thing to think about  unless depression is too 
much, like when you receive a client who is 
crying and you try to find out a medical problem 
causing those tears and you don’t find it”. That 
time you may suspect about depression”. 
When the researcher  asked to know if all 
participants would suspect depression from 
certain signs and symptoms, some responded 
that it was not usually the case. One participant 
said, “Sometimes you don’t see it, it is like you 
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are blind and your mind is on the medical 
problem”. 
 
Referral of the patient to the mental unit 
without follow-up: The researcher wanted to 
know what happened when a doctor suspected 
depression in a patient. Did he/she let the patient 
continue like that or was something done? 
Participants answered that when a medical 
doctor suspects depression while caring for a 
patient, he treats the medical problem, and then 
refers the patient to the mental unit. The 
responses indicates that this referral would not 
be official but just advice to the patient. One 
participant said, “Oh, this transfer is not an 
official one, it is just advising the patient to go 
and see the mental nurse and they are no 
documents used and no follow up.”  
 
Common chronic NCDs associated with 
depression: Cardiac diseases, diabetes and 
asthma were the diseases which participants 
reported as those most frequentlyassociated with 
depression in their hospitals. One participant 
commented as follows: 
“… because patients with those 
diseases are always stressed, 
wondering if they will live tomorrow or 
next tomorrow. 
.. Let’s take diabetes, patients with 
diabetes always say “I fear that I may 
die of hyperglycaemia or 
hypoglycaemia any time of the day 
..see people with cardiac diseases: 
“Doctor I fear that I sleep and go…, I 
die because of my heart. 
..imagine people with asthma:“Doctor, 
imagine if I forgot my inhaler with 
salbutamol, I don’t want to think what 
will happen to me. 
..Imagine these people living in every 
day fear, this is what called depression 
”. 
Screening tools of depression in patients with 
NCDs: Tools to screen for depression such as 
Patient Health Questionnaire-9 (PHQ-9) and 
Beck Depression Inventory (BDI) exist in 
district hospitals, and mental nurses use them 
every day to screen for depression. The surprise, 
however, was that mental nurses were not aware 
that these tools are also highly recommended for 
screening for depression among patients with 
chronic NCDs, PHQ-9 in particular(15).  
Particular protocols orinterventions to 
manage co-morbidity of depression and 
NCDs 
No particular protocols or specific 
interventions: All participants confirmed that 
no particular protocols or interventions existed 
to manage this co-morbidity. One participant 
said, “I don’t think we do have such protocol or 
interventions in our hospital. You know as we 
said earlier, if a medical doctor thinks that this 
person may have depression, then he/she will 
ask him/her to go to the mental unit. It is that 
all”. 
Separate treatment by separate health 
professionals: The participants made it clear 
that for them depression and NCDs are different 
diseases, treated separately and by different 
health professionals in their hospitals. One of the 
participants said, “Depression is treated in 
mental units by mental professionals and NCDs 
are treated in medical units by medical 
professionals. We may also facilitate the 
transfer, but really we do not go beyond”. 
 
No Follow up: It was clear from the discussion 
that no follow-up was done by medical 
professionals once they had asked the patient to 







Table 2: Categories and sub-categories emerging from questions on management of co-morbidity in 
Rwanda 
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Meaning of  co-morbidities More than one disease in the same person 
Occurrence of a disease from another one in a person 
Common co-morbidities Diabetes and hypertension 
Diabetes, hypertension and gastritis 
Diabetes, hypertension and asthma 
Diabetes, hypertension and depression 
Renal failure and depression 
Awareness of co-morbid depression with 
chronic NCDs 
Awareness of the occurrence of depression in chronic NCDs 
Non-focus on depression 
Suspected by some signs and symptoms 
Referral of the patient to the mental unit 
No follow up  
Common chronic NCDs associated with 
depression 





Screening tools of depression in patients 
with chronic NCDs 
No tools 
PHQ-9 to screen depression in Patients with HIV+ 
PHQ-9,BDI in psychiatric hospitals to screen depression in 
general  
Particular protocol No particular protocol 
Interventions to manage the co-
morbidity of depression and chronic 
NCDs 
No specific interventions 
Referral in the mental unit 
Separate treatment 
No follow up 
 

































































due the lack 
of follow up 
DISCUSSION  
 
Awareness of co-morbid depression and 
chronic NCDs among health professionals 
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(research team), and frequent NCDs 
associated with depression 
The study found that the health care 
professionals were aware that depression can 
occur at any time in a patient with one or more 
chronic illnesses because of stress, fear or anger 
resulting from chronic illnesses. However, 
almost all the health professionals agreed that 
depression is mostly unrecognized in patients 
with chronic illnesses, either because the focus 
is on the medical condition or simply because of 
confusion between medical signs and depression 
signs. These findings correspond with those 
confirmed by other authors. According to Simon 
(22), the presence of a chronic medical illness 
may reduce the possibility that physicians or 
other health care providers recognize or treat 
depression. Studies have also confirmed that 
depression is under-diagnosed and under-treated 
close to 50% to 65% of the time in primary 
health care settings (23-26). 
The study found that diabetes, hypertension 
and asthma were the conditions most reported by 
health professionals as associated with 
depression. They explained that these diseases 
are regarded by most patients as portending 
imminent death. These qualitative findings were 
confirmed by quantitative findings of this study 
that found out tha tdepression was higher in 
patients with diabetes and hypertension (83.8%). 
These findings confirm those from a systematic 
review of 31 studies in which higher numbers 
for depression were found in certain chronic 
illnesses thatincluded diabetes, asthma and  
cardiovascular diseases (27). Polsky et al.(28) 
also reported that lung diseases and heart 
diseases are among those most associated with 
depressive patients. Other diseases reported by 
Kang et al. (29) as particularly associated with 
depression included cancer, stroke and acute 
coronary syndrome. 
 
Screening tools to diagnose depression among 
patients with chronic NCDs 
 
The findings revealed that in medical units at the 
district level, there were no specific screening 
tools to diagnose depression among patients 
with NCDs. Although the PHQ-9 questionnaire 
was available in mental health units of these 
hospitals, mental nurses had been trained by the 
Ministry of Health to use this tool to screen for 
depression only in patients with HIV/AIDS.   
Unfotenately the same nurses were not aware 
that the tool can be also used to screen for 
depression among patients with NCDs. Its use is 
in fact recommended by the WHO for this 
specific purpose (15). We also found that the 
BDI was available at the psychiatric referral 
hospital for screening for depression in general. 
The tools most recommended by researchers for 
use in screening for depression among patients 
with NCDs are PHQ-9 and BDI (15, 30-32). 
Our findings suggested non-availability for 
medical staff at district level of depression 
screening tools for use among patients with 
NCDs. Screening tools should made available to 
medical doctors who should also receive training 
on how to use these tools to screen for 
depression among patients with NCDs. Early 
diagnosis of depression in patients with chronic 
illnesses is widely supported and recommended 
(15, 33, 34). 
 
Protocols or interventions to manage co-
morbidity of depression and NCDs  
 
The study found that no specific protocols or 
interventions were in place for managing co-
morbidity of depression and chronic NCDs in 
the participating district hospitals. When co-
morbidity was present, it was handled through 
separate treatments by separate medical health 
and mental health professionals. There was no 
collaboration between these health care 
providers in treating this co-morbidity, and there 
was no follow-up from medical doctors who 
may have advised the patient to consult in the 
mental unit. This separated treatment of co-
morbid depression and chronic NCDs is not 
unique to Rwanda and is encountered in most 
developing countries, as has been shown by 
Clarke and Currie (17). 
Despite WHO’s recommendation of 
collaborative management of this co-morbidity 
between mental and medical professionals (13), 
separated treatment persists (17). 
This separate treatment continues to be 
associated with health complications such as 
complex medication regimens with high risk of 
drug interactions and poor medication 
adherence, duplicative medical tests, 
unnecessary hospitalizations, and worsening 
mortality (13-15). 
               Ethiop J Health Sci.                               Vol. 27, No. 1                           January  2017 
 
 




An important point here is that in Rwanda 
there is decentralized care of chronic NCDs at 
the primary level (district level) in a program 
known as “Integration of human resources for 
chronic care” in which a group of health 
professionals (4-10 generalist physicians, 2-3 
chronic NCD nurses, 4-5 HIV and TB nurses 
and 2-3 neuropsychiatric nurses) are assigned to 
the district hospitals to care for chronic illnesses. 
Based on our findings, however, despite this 
integration of human resources, there is no 
evident collaborative strategy between these 
professionals and cases are seen and treated 
separately. 
In most developed countries, collaborative 
care is used in various settings, including the 
primary health care level, to manage the co-
morbidity of depression and chronic NCDs such 
diabetes, hypertension and certaint ypes of 
cancers, and has been proven cost effective for 
this purpose (13-15). A randomised controlled 
trial in 14 primary care clinics in Washington 
State studied patients with depression and poorly 
controlled diabetes, or coronary heart disease, or 
both, and concluded that, compared with care as 
usual, collaborative care led to significant 
improvement in the management of depression 
and chronic diseases (32). 
Ali et al. (35) and Carney & Freedland (36) 
argued that management of chronic non-
communicable disorders based solely on the 
treatment of a single diagnosis is flawed from 
the public health perspective. This is because 
these chronic diseases are usually accompanied 
by variousco-morbidities such as hypertension, 
cardiovascular disease and, most commonly, 
depression, resulting in competing demands 
when patients seek care from different 
clinicians. 
In conclusion, our finding on absence of 
protocols or interventions to manage the co-
morbidity of depression and chronic NCDs 
means that patients with this co-morbidity 
continue to receive separated treatments that can 
have serious health consequences for them. We 
therefore suggest that there should be a shift 
from separate treatment of this co-morbidity to 
collaborative treatment in line with WHO’s 
recommendations. This could be achieved by 
forming the collaborative  care team constituted 
by a medical doctor, a mental health nurse and a 
registered nurse based at the district hospital.  
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